General Information of Synthetic Binding Protein (SBP) (ID: SBP001855)
SBP Name
DART anti-cadherin/CD3 34
Synonyms
DART CD3 34
Design Method Traditional methods (Site-directed mutagenesis and/or Directed evolution)
Expression System Human embryonic kidney?cells 293
Selection Method Phage display
Highest Status Research
SBP Sequence
>VH CDR1
SYGIS
>VH CDR2
WISAYNGNTNYAQKLQG
>VH CDR3
IDTASAFDI
>VL CDR1
SGSSSNIGNNYVS
>VL CDR2
DNNKRPS
>VL CDR3
GTWDSSLSAWV
Protein Scaffold Information of This SBP
Scaffold ID PS028
Scaffold Info
[1]
Scaffold Name DART
Scaffold Class Antibody fragment
Fold Type Beta-Sheets + Loops
Binding Target(s) of This SBP (BTS)
BTS Name Details Mechanism Application Affinity Research Organization Ref
T-cell surface glycoprotein CD3
BTS Info
Binder Cancers [ICD-11: 2D4Z] Kd: 21.9 nM Pfizer [1]
Cadherin-3
BTS Info
Binder Cancers [ICD-11: 2D4Z] Kd: 129.3 nM Pfizer [1]
References
1 Development of PF-06671008, a Highly Potent Anti-P-cadherin/Anti-CD3 Bispecific DART Molecule with Extended Half-Life for the Treatment of Cancer. Antibodies (Basel). 2016 Mar 4;5(1):6.